Revance Therapeutics Inc (RVNC) News

The deal is subject to regulatory approvals and other conditions and is anticipated to close by the end of 2024.

This statement and the frequent very short term extensions to the tender date make me suspect that there will be a definitive result before the end of this month. … and it’s not likely to make the current shareholders very happy.

How many times are you going to repeat the same sentiment? We get it, you hate RVNC and feel anyone holding shares is naive and foolish. Sheesh. Give it a rest.

Nothing displays a lack of confidence and childishness like recommending your own post.

Extract from the August 12 PR.

Revance CEO Mark J. Foley stated that the merger provides substantial value to shareholders while expanding the combined company’s product portfolio and provider network. The deal is subject to regulatory approvals and other conditions and is anticipated to close by the end of 2024.

This statement and the frequent very short term extensions to the tender date make me suspect that there will be a definitive result before the end of this month. … and it’s not likely to make the current shareholders very happy.

All the same, GLTA You are going to need it.
.

Ian, your problem is u always talk like u know things but most of your posts tell us otherwise. You didn’t just express opinion, you once again, is spreading false information intentionally.

You make me laugh little man. Honestly nobody on this site cares and if you’re sooo sure of your faulty intel, then shut up and show us all by buying 300,000 short shares. Please do it 🤭🤭🤭🤭

Why do you believe that you will have any benefit from future Daxx revenues?

In the unlikely event that Crown Labs buys RVNC, you’ll get nothing other than whatever Crown agrees to pay for the shares of RVNC. … and that could be zero if they walk away. The market seems to think that that number is going to be less than $4 per share.

If Crown walks away, there’s a high probability that RVNC will go under in much less than a year. In that case, you’ll get nothing for your shares and no part of any future Daxx revenue. Whatever entity buys the IP will get all Daxx revenue going forward.

Existing shareholders will be totally and absolutely wiped out. I promise to come back and tell you “I told you so“. … pal

There’s no point in saying “GLTY“, because you’ve already chosen the route that will give you the least ROI possible.

Utterly amazing investing skills!!!

No emerging biotech that’s declared itself to be a going concern has ever been able to raise any capital.

I would be very surprised if RVNC were to become the first.

Try not to lie so poorly that one can easily disprove it.

https://rapport.bio/all-stories/going-concern-clauses-not-always-concerning

Ahhhhhhh. We hurt his feelings. 😂😂. The fact is DAXXIFY has value and cannot be replicated without years of R&D and close to a billion dolllars. Thats what we’re investing in, not Foley. Don’t go away mad pal, just go away

100% agree

Do you have a better opinion?

… Or do you even have an opinion?

Tell us your opinion, and then we can see whose opinion turns out to be more accurate.

Mine is based on the publicly known reality. But, then again, you don’t seem to have any faith at all or any understanding at all, of reality.

Ian is an idiot and knows nothing about what’s going on. DAXXIFY is a special products that doctors and patients are loving the results. Yes management sucks, but the company will not only survive, but thrive. I’m holding

Ian, is this one of those i made a false claim because i didn’t know better moment? Again?

No emerging biotech that’s declared itself to be a going concern has ever been able to raise any capital.

I would be very surprised if RVNC were to become the first.

My guess is that RVNC has been trying left right and centre to either find another bidder or get some more money. … Unsuccessfully.

IMHO

Pretty negative accessment here given CD and China approvals should help top line next year. Thats what makes the market i guess

Stock was pushing 2.5 shortly before deal news were made “public”. Now you have Evolus entering filler market and going concern note from the dumbest idiot ceo.[/quot

For these reasons, I think the stock hits low 1s or below if deal crashes. I am amazed that some here think that "going concern" issue is not real, and will not crash the stock price if there is no deal. Still can do a financing to save company but very low value.

JMO.

Would management grant themselves more options before closing the deal? Now it's so close to year end.

I am never surprised at the level of unbridled greed management of companies is capable of. Elon Musk is the text book example of that.

But then now, it seems everybody else is saying the bid might have been too high for Crown?

Unless the bid is too low for Teoxane. Of course, NOBODY knows on this board knows what is going on despite Ian acting as if he knows.

Stock was pushing 2.5 shortly before deal news were made “public”. Now you have Evolus entering filler market and going concern note from the dumbest idiot ceo.

Would management grant themselves more options before closing the deal? Now it's so close to year end.

$RVNC closed at 3.53 before the deal was announced. Since then, they got couple approvals from China along with some milestones payments (and royalty should be coming in soon), strengthen the agreement to Tex (by giving away something that RVNC won't have resource to deal with anyways). Attached an offer from Crown for $6.66. Now stock trades back down to pre-deal level.

But then now, it seems everybody else is saying the bid might have been too high for Crown? Who knew.
=======================================

Probably close to no one.

That’s why the experts advise us not to act as arbitrageurs.

yeah.. so bizzard... and I was thinking we might see a competing bid before they tender couple months back or the tender would fail because major shareholders would think it's too low. But then now, it seems everybody else is saying the bid might have been too high for Crown? Who knew.

I have never seen anything like this RVNC buyout deal, delay after delay. I hope to never see it again. I feel like Charlie Brown running up to kick the football and Lucy pulls it away at the last minute. Rinse and repeat.

We all think BoD got us awful price but the odd thing is so far no one other than Crown willing to buy RVNC out. Otherwise, Crown won’t have a chance to take so long to squeeze Foley.

I really don’t think they are talking about break-up fee as if so, they could have mentioned by now and RVNC will need to tell the investment communities their go-forward plan without a buyout. Your argument makes sense, but it is not dispositive, IMO.

RVNC’s BoD already shirked its fiduciary duty by agreeing to the Crown deal in the first place, so it’s not hard to envision the same BoD sitting idly by while investors are mistreated by not being told about a go-forward plan.

RVNC tender delayed until 12/9/24 (or later):

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001479290/000114036124048480/ef20039621_8k.htm

Other than the date, there are no changes to the language in the 8-K pertaining to the buyout “deal.”

It almost feels like management is trolling us lol

Dec 9 is Monday. So technically, it is still 2 business days.

UnREAL is understatement but this is not pennyland and Advisors* to ‘transaction’ are acting like it!!!

If there are open questions to ANYTHING, why not go Monthly/Bi, not 2day , 3day …Truly a Case Study …Nevr I have I EVER( 54yrs of Markets) wow

*Legal & Financial

I really don’t think they are talking about break up fee as if so, they could have mentioned by now and RVNC will need to tell the investment communities their go forward plan without a buyout.

This distraction is unreal.

Literally crazy land

Dec 9th!! Lmao…’never have I ever’—think that was a drinking game ( called charade’s or Tender, or l…)
Wow

https://ih.advfn.com/p.php?pid=nmona&article=95046264&_gl=1*6jkqmo*_gcl_au*ODQyNDIxNDQ1LjE3MjY0MjkyNjk.

And all positions are being held at 4% average if all shares, keeping them all just under the 5% ownership filing rule, except BlackRock, who also just happens to have a $3.88 average share price, but they own 9% of all outstanding shares. Strange stuff going on

I can’t paste photos on here for some reason, but look at Sage Tracker for Institutional positions and you’ll see them all.

Can anyone explain why there was like 50,000,000 new Institutional positions positions taken recently and ALL closed at $3.88 per share. No way that’s even possible unless someone planned it.

What are the chances that the delay is due to a new buyer want to join force with Crown, like TEOXANE

100% agree and they had a line of credit that they never used in 2023

Therapeutic alone could bring in 100s of millions od sales over time and Daxxify has clear advantage there.

Revance should just raise additional capital to keep pushing forward rather than giving up all upside hy selling out at 6 bucks.

Dew is stating his opinion, not giving fiduciary advice. Plenty of people have disagreed with Dew on numerous occasions.

Dew can be wrong, as all of us can, especially in biotech. I admit, most biotechs go up after FDA approval of their main product, but RVNC has been the exception, not the rule.

You are not paying Dew for their advice. You don’t even pay to post on iHub.

I publicly stated that I sold all my RVNC, at a substantial loss, within days of their initial announcement of the $6.66 buyout. I’m glad I did. Other people sold when the stock was at $36, oh so long ago, and said so, while others hold on, hoping for better days. That’s what makes a market.

If you only listen to what Dew says, and not others, that’s on you.

If you want someone to blame, look to Foley and RVNC management. It shouldn’t take um-teem times to close a sale and take the company private, leaving all the investors in a publicly traded company twisting in the wind.

It says milestone payments (plural), which I take to mean separate milestone payments for each of the two indications.

Thanks Dew. It would be nice if Foley had thought about mentioning this.

Yes, RVNC is due a (probably modest) milestone payment from Fosun Pharma for China’s approval of Daxxify in CD. From RVNC’s 2023 10-K (page 11):

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001479290/000147929024000038/rvnc-20231231.htm In April and July 2023, the NMPA accepted Fosun’s BLA for DaxibotulinumtoxinA for Injection for the improvement of glabellar lines and treatment of cervical dystonia, respectively. The anticipated approvals for both indications are expected in 2024. We are entitled to receive additional milestone payments from Fosun upon approval of DaxibotulinumtoxinA for Injection in China… It says milestone payments (plural), which I take to mean separate milestone payments for each of the two indications.

Meanwhile, China approved Daxxify for cervical dystonia.

Is there any milestone for this approval? I wonder if Teoxane is getting mad that Foley undervalued the potential money from Daxxify sales in China in accepting the current bid of $6.66 and they are pushing for either a higher price or for the deal to end.

Stocksrising, thanks for the post that was more complete than mine on this topic. I posted mine before reading yours. We are on the same page.

cervical dystonia is not the only medical condition they use DAXXIFY for. Any condition like Pudendal neuralgia or any nerve condition that creates spasms it’s highly recommended and being used more and more, because it last twice as long as Botox, which they’ve been using for years for the same purposes, and on an in very increased basis year over year. This may not be a huge income stream in the short term, but Revance and other know the potential to be huge.

2 days extension now, its like Xmas count down

As many of us speculated, Price paid adjustments and teoxone relationship along with breakup fee’s are prob holding up Tender but could this Fosun approval move the needle??
Don’t know if ~70k Chinese market will mean much, but this brings more markets opened for Crown if successful and mr. market likes this release..I’m sure market also likes a 2 day extension( perhaps final , lol)


From Bing AI:
How many people in China have cervical dystonia?
Copilot—

Cervical dystonia, also known as spasmodic torticollis, is a neurological disorder characterized by involuntary muscle contractions in the neck, leading to abnormal movements and postures of the head and neck. In China, the prevalence of cervical dystonia is estimated to be around 4.98 per 100,000 people 1 2. This means that in a population of approximately 1.4 billion, there could be around 69,720 individuals affected by this condition.

RVNC tender delayed until 12/5/24 (or later):

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001479290/000114036124048244/ef20039450_8k.htm

Meanwhile, China approved Daxxify for cervical dystonia.

For the nth time, hope we can move on from Crown and Foley fired.

I stated many times that Foley was a total idiot! Many Allergan executives told me they would never join or be part of a company that Foley runs! The guy is a narcissist and total train wreck!

Teoxane is the only company that would love to take over Revance! I hope Teoxane gets the chance to showcase Daxi and kicks Foley to the curb!!!

I have never knowingly spread any false information of any nature whatsoever.

No, you just accused/lied that others who had a different opinion than you of knowingly spread false information. I find it despicable.

If the permabulls had listened to what I have said on this board, they would’ve sold their shares at much higher prices, and been a lot wealthier than they are today. If they (you) still felt that the company is a worthwhile risk, they could’ve used some of the profits that they would’ve taken to buy practically any number of shares with money that they felt like throwing in the garbage can.

What a pathetic little self-serving screed! So if you were such a genius you must have shorted RVNC and made a fortune, right?

Rather than repeatedly attack and demean others who had a different view of RVNC's prospects, why don't you use your financial genius and give of 4 or 5 excellent biotech risks where we can invest our hard earned money? It should be child's play for such a self-proclaimed financial guru as yourself.

You dont have names. I knew it. ;)

Why would I share names with you?

All you’ve done is ignore me and to attack me.
… And lose money while doing so.